Diencephalic Syndrome: Misleading Clinical Onset of Low-Grade Glioma.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
13 09 2023
Historique:
received: 15 05 2023
revised: 26 06 2023
accepted: 08 07 2023
medline: 4 10 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

Diencephalic Syndrome is an atypical early manifestation of low-grade gliomas; so, it is important to detect it in patients that experience a failure to thrive despite adequate length growth and food intake. The purpose of this article is to focus attention on this rare but potentially dangerous cause of poor weight gain or stunting in childhood. We describe four patients with Diencephalic Syndrome and low-grade gliomas who were evaluated in our institution from January 2017 to December 2021. two patients presented with suspected malabsorption, and two presented with a suspected eating disorder. In all cases, neurological symptoms appeared late, explaining the reason for the diagnostic delay, which impacts negatively on prognosis and on quality of life. Currently, patients 1 and 2 have stable disease in second-line therapy, patient 3 has stable disease post end of second-line therapy, and patient 4 has stable disease in first-line therapy. Everyone is in psychophysical rehabilitation. A multidisciplinary evaluation is essential in order to make an early diagnosis and improve prognosis and quality of life.

Sections du résumé

BACKGROUND
Diencephalic Syndrome is an atypical early manifestation of low-grade gliomas; so, it is important to detect it in patients that experience a failure to thrive despite adequate length growth and food intake. The purpose of this article is to focus attention on this rare but potentially dangerous cause of poor weight gain or stunting in childhood.
MATERIALS AND METHODS
We describe four patients with Diencephalic Syndrome and low-grade gliomas who were evaluated in our institution from January 2017 to December 2021.
CASE DESCRIPTION AND RESULTS
two patients presented with suspected malabsorption, and two presented with a suspected eating disorder. In all cases, neurological symptoms appeared late, explaining the reason for the diagnostic delay, which impacts negatively on prognosis and on quality of life. Currently, patients 1 and 2 have stable disease in second-line therapy, patient 3 has stable disease post end of second-line therapy, and patient 4 has stable disease in first-line therapy. Everyone is in psychophysical rehabilitation.
CONCLUSIONS
A multidisciplinary evaluation is essential in order to make an early diagnosis and improve prognosis and quality of life.

Identifiants

pubmed: 37754525
pii: curroncol30090610
doi: 10.3390/curroncol30090610
pmc: PMC10529672
doi:

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8401-8410

Références

Handb Clin Neurol. 2016;134:329-44
pubmed: 26948364
Pediatr Blood Cancer. 2018 May;65(5):e26917
pubmed: 29369501
J Pediatr. 1976 Mar;88(3):439-44
pubmed: 1245953
Cancers (Basel). 2022 Jan 31;14(3):
pubmed: 35159015
An Esp Pediatr. 2002 May;56(5):466-71
pubmed: 12042123
Pediatrie. 1983 Sep;38(6):401-9
pubmed: 6664747
Arch Neurol. 1977 May;34(5):295-7
pubmed: 67836
Ital J Pediatr. 2022 Aug 17;48(1):147
pubmed: 35978327
J Pediatr Gastroenterol Nutr. 2000 Apr;30(4):453-7
pubmed: 10776962
J Med Assoc Thai. 2004 Aug;87(8):984-7
pubmed: 15471306
J Psychiatr Res. 2022 Apr;148:240-249
pubmed: 35149436
Neurology. 2016 Nov 22;87(21):e248-e251
pubmed: 27872228
Childs Nerv Syst. 2023 May;39(5):1115-1122
pubmed: 36752912
J Neurooncol. 2006 Sep;79(2):197-201
pubmed: 16598421
Clin Endocrinol (Oxf). 1980 Aug;13(2):181-7
pubmed: 7438472
Pediatrics. 2005 Jun;115(6):e742-8
pubmed: 15930202
Surg Neurol. 1985 Jun;23(6):581-8
pubmed: 3992458
Clin Radiol. 1974 Jan;25(1):153-6
pubmed: 4547625
Childs Nerv Syst. 2022 Oct;38(10):2033-2035
pubmed: 35507081
Eur Child Adolesc Psychiatry. 2013 Jul;22(7):443-50
pubmed: 23296472
Klin Padiatr. 2007 Mar-Apr;219(2):91-4
pubmed: 17405074
Cancer. 1997 Jul 1;80(1):142-6
pubmed: 9210720
Surg Neurol. 1982 Feb;17(2):141-6
pubmed: 6803375
Arch Neurol. 1973 Feb;28(2):139-40
pubmed: 4683151
AJNR Am J Neuroradiol. 1997 Sep;18(8):1499-505
pubmed: 9296191
Diagnostics (Basel). 2022 Mar 09;12(3):
pubmed: 35328218
BMJ Case Rep. 2017 Jul 6;2017:
pubmed: 28687692
J Pediatr Neurosci. 2018 Oct-Dec;13(4):383-387
pubmed: 30937076

Auteurs

Milena La Spina (M)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Manuela Caruso (M)

Pediatric Endocrinology and Diabetology Center, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Carmela Gulizia (C)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Mattia Comella (M)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Rachele Soma (R)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Mariaclaudia Meli (M)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Piera Samperi (P)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Gregoria Bertuna (G)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Andrea Di Cataldo (A)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Giovanna Russo (G)

Pediatric Hematology and Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH